Related Experiment Video
Updated: May 29, 2026

11:35
Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)
Published on: August 21, 2016
A general framework for detecting disease associations with rare variants in sequencing studies
1Department of Biostatistics, University of North Carolina, Chapel Hill, NC 27599, USA.
American Journal of Human Genetics
|September 3, 2011
Summary
Rare variants significantly contribute to complex diseases. This study introduces a powerful and efficient framework for analyzing rare variants, identifying genetic associations with diseases like high cholesterol.
Area of Science:
- Genetics
- Bioinformatics
- Computational Biology
Background:
- Rare variants are increasingly recognized for their substantial role in complex human diseases.
- High-throughput sequencing technologies now enable extensive rare variant data generation in large populations.
Purpose of the Study:
- To develop a generalized framework for association testing of rare variants.
- To integrate mutation information across multiple sites within genes for enhanced genetic analysis.
- To accommodate diverse study designs, phenotypes, and covariates.
Main Methods:
- A novel framework combining mutation information from multiple variant sites within genes.
- Utilizing appropriate regression models to link genetic data to disease phenotypes.
- Deriving theoretically optimal procedures for combining rare mutations and constructing test statistics.
- Allowing for fixed or variable allele-frequency thresholds and varied mutation effect directions.
Main Results:
- The proposed methods demonstrate superior statistical power and computational efficiency compared to existing approaches.
- Successfully applied to a deep-resequencing study, identifying rare variants associated with total cholesterol.
- The framework is versatile, supporting various study designs (case-control, cohort, etc.) and phenotypes (binary, quantitative).
Conclusions:
- The developed framework provides a robust and efficient approach for rare variant association testing.
- This methodology facilitates the discovery of novel genetic associations for complex diseases.
- Associated software is publicly available, promoting wider research application.
Related Concept Videos
Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...

